GlassScriptPhysician profile
Gregory Lawton Eaves
NPI 1487737821
$64,740.77
in general payments reported to CMS, 2019-2025
47 companies · $4,786 in 2025
The $4,786 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,789 · 2020: $4,241 · 2021: $2,590 · 2022: $741 · 2023: $28K · 2024: $18K · 2025: $4,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Food and Beverage: $3,063 · Travel and Lodging: $1,989 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45,303.12 |
| Food and Beverage | $3,062.69 |
| Travel and Lodging | $1,988.68 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $49,869.27 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $9,582.73 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $878.36 | 2019-2021 | |
| Inari Medical, INC. | $570.86 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $563.18 | 2021-2024 | Watchman Flx, Watchman Access System, Eluvia |
| Abbott Laboratories | $461.80 | 2019-2025 | Cardiomems, Diamondback Coronary, Mitraclip |
| Novartis Pharmaceuticals Corporation | $268.57 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $232.61 | 2020-2025 | Wainua, Farxiga |
| Merck Sharp & Dohme LLC | $211.97 | 2021-2025 | Verquvo, Belsomra |
| Janssen Pharmaceuticals, INC | $200.75 | 2019-2024 | Xarelto |
| Medtronic, INC. | $149.20 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Valiant Captivia |
| Pfizer INC. | $146.16 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.58 | 2019-2024 | Jardiance |
| Lundbeck LLC | $114.87 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.82 | 2022-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $88.01 | 2022-2024 | Camzyos, Eliquis |
| Abiomed | $79.63 | 2023 | Impella |
| Tolmar, INC. | $73.06 | 2023-2024 | |
| Lilly USA, LLC | $72.22 | 2022-2025 | Zepbound, Mounjaro |
| Lexicon Pharmaceuticals, INC. | $69.98 | 2024 | |
| Cook Medical LLC | $69.47 | 2024 | Rosen |
| Sanofi-Aventis U.S. LLC | $67.34 | 2019-2023 | |
| Cardiva Medical, INC. | $65.27 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Arbor Pharmaceuticals, INC. | $59.27 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $54.85 | 2022-2023 | Arcalyst |
| Chiesi USA, INC. | $53.63 | 2019-2022 | |
| Amarin Pharma, INC. | $47.74 | 2020-2021 | |
| Esperion Therapeutics, INC. | $43.26 | 2025 | Nexletol |
| Cvrx, INC. | $39.73 | 2023 | Barostim Neo System |
| Biotronik INC. | $38.58 | 2019-2023 | Rivacor 7 Dr-T, Biomonitor, Acticor 7 Vr-T Dx |
| Shockwave Medical, INC | $32.02 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardinal Health 200 LLC | $30.12 | 2019 | |
| Medtronic Vascular, INC. | $25.99 | 2019-2020 | |
| Cardiovascular Systems INC. | $25.21 | 2020-2023 | Diamondback Coronary |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| United Therapeutics Corporation | $19.19 | 2019 | |
| Scpharmaceuticals INC. | $18.01 | 2023 | |
| Verity Pharmaceuticals INC. | $16.90 | 2025 | Tlando |
| Solventum Corporation | $16.58 | 2025 | Activ.A.C., Promogran Prisma |
| Kiniksa Pharmaceuticals International, Plc | $16.05 | 2024 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $15.52 | 2023 | Adthyza |
| Baxter Healthcare | $15.05 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Astellas Pharma US INC | $14.97 | 2019 | |
| Terumo Medical Corporation | $14.87 | 2023 | Glidesheath Slender, Glidewire |
| Itamar Medical INC | $14.76 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.58 | 2019 | |
| Organogenesis INC. | $13.18 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Eaves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.